Results 31 to 40 of about 249,373 (343)

Outcomes of Hospitalizations for Cardiogenic Shock at Left Ventricular Assist Device Versus Non–Left Ventricular Assist Device Centers

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2020
Background Cardiogenic shock (CS) is a complex syndrome associated with high morbidity and mortality. In recent years, many US hospitals have formed multidisciplinary shock teams capable of rapid diagnosis and triage. Because of preexisting collaborative
Joseph I. Wang, Daniel Y. Lu, MHS, Dmitriy N. Feldman, Stephen A. McCullough, Parag Goyal, Maria G. Karas, Irina Sobol, Evelyn M. Horn, Luke K. Kim, Udhay Krishnan   +10 more
doaj   +1 more source

Optimal timing of heart transplantation in patients with an implantable left ventricular assist device

Korean Journal of Transplantation, 2023
Heart transplantation (HTPL) has been established as the gold-standard surgical treatment for end-stage heart failure. However, the use of a left ventricular assist device (LVAD) as a bridge to HTPL has been increasing due to the limited availability of ...
Suk Ho Sohn, Yoonjin Kang, Ho Young Hwang, Hyun Keun Chee   +3 more
doaj   +1 more source

The influence of left ventricular assist device inflow cannula position on thrombosis risk

Artificial Organs, 2020
The use of left ventricular assist devices (LVADs) as a treatment method for heart failure patients has been steadily increasing; however, pathological studies showed presence of thrombi around the HeartWare ventricular assist device inflow cannula (IC ...
M. Ghodrati, Alexander Maurer, T. Schlöglhofer, Thananya Khienwad, D. Zimpfer, D. Beitzke, F. Zonta, F. Moscato, H. Schima, P. Aigner   +9 more
semanticscholar   +1 more source

Hybrid closure of ventricular septal defect and implantation of systemic right ventricular assist device

ESC Heart Failure, 2022
A 50‐year‐old female patient was readmitted with refractory systemic right ventricular failure. The patient underwent a Mustard procedure during childhood for transposition of the great arteries.
Jerome Soquet, Ali Houeijeh, Marjorie Richardson, Eleonore Hebbar, Guy Vaksmann, Jean‐Benoit Baudelet, Mouhamed Djahoum Moussa, Andre Vincentelli   +7 more
doaj   +1 more source

Left Ventricular Assist Device (LVAD) Implantation and Renal Dysfunction [PDF]

Ķazaķstannyṇ Klinikalyķ Medicinasy, 2018
Pathophysiological, pathomorphological and functional changes in the kidneys after left ventricular assist device implantation have not yet been fully understood and represent an actual problem of our time.
Assem Nogaibayeva, Bagdat Sultanova, Myrzabek Makhmutov   +2 more
doaj   +1 more source

Cost-effectiveness of left ventricular assist devices (LVADs) for patients with advanced heart failure : analysis of the British NHS Bridge to Transplant (BTT) program [PDF]

, 2001
Background: A previous cost-effectiveness analysis showed that bridge to transplant (BTT) with early design left ventricular assist devices (LVADs) for advanced heart failure was more expensive than medical management while appearing less beneficial ...
Aileen Clarke, Ruth Pulikottil-Jacob, Martin Connock, Gaurav Suri, Ngianga-Bakwin Kandala, Hendramoorthy Maheswaran, Nicholas R. Banner, Paul Sutcliffe, Aaronson, Garber, Weinstein, Slaughter, Temple, MacGowan, Clegg, Clegg, Sharples, Sharples, Sharples, Slaughter, Sharples, National Institute for Health and Clinical Excellence, Gohler, Rogers, Personal social services research unit, Briggs, Levy, Schaffer, Strueber, Rose, Stevenson, National Institute for Health and Clinical Excellence, Moreno, Pagani   +33 more
core   +6 more sources

Methodological Study of Reliability Test of Percutaneous Ventricular Assist Device

Zhongguo yiliao qixie zazhi
Prior to clinical application, reliability of percutaneous ventricular assist devices(pVAD) requires to be tested systematically. Currently, there's a lack of dedicated reliability testing equipment and methodologies for pVAD.
Xun LIU, Da ZHU, Yujing ZHANG, Xiangbin PAN   +3 more
doaj   +1 more source

Long-Term Survival of Patients With Advanced Heart Failure Receiving an Left Ventricular Assist Device Intended as a Bridge to Transplantation

Circulation: Heart Failure, 2020
Background: The paucity of available hearts for transplantation means that more patients remain on durable left ventricular support for longer periods of time.
D. Zimpfer, A. Fiane, R. Larbalestier, S. Tsui, P. Jansz, A. Simon, S. Schueler, M. Strueber, J. Schmitto   +8 more
semanticscholar   +1 more source

Use of Right Ventricular Assist Device Post-Left Ventricular Assist Device Placement

Hearts
Right heart failure (RHF) is a common manifestation after left ventricular assist device (LVAD) placement and is associated with a high mortality rate. Historically, RV failure requiring an RVAD at the time of LVAD implantation has been associated with ...
Shannon Parness, Tori E. Hester, Harish Pandyaram, Panagiotis Tasoudis, Aurelie E. Merlo   +4 more
doaj   +1 more source

Targeted myocardial gene expression in failing hearts by RNA sequencing

Journal of Translational Medicine, 2016
Background Myocardial recovery with left ventricular assist device (LVAD) therapy is highly variable and difficult to predict. Next generation ribonucleic acid (RNA) sequencing is an innovative, rapid, and quantitative approach to gene expression ...
Kajari Dhar, Alexandra M. Moulton, Eric Rome, Fang Qiu, Jeff Kittrell, Eugenia Raichlin, Ronald Zolty, John Y. Um, Michael J. Moulton, Hesham Basma, Daniel R. Anderson, James D. Eudy, Brian D. Lowes   +12 more
doaj   +1 more source